Specifically, we applied genetic proxies for l-carnitine to genome-wide association studies (GWAS) of CVD and its risk factors (type 2 diabetes, glucose, HbA1c, insulin, low-density lipoprotein (LDL)-cholesterol, high-density lipoprotein (HDL)-cholesterol, triglycerides, apolipoprotein B, and blood pressure)
Because of the incredible success of modern medical management and GLP-1 medications, many patients no longer face the historical mandate of needing four separate, exhausting surgeries
It used to be that a loss of 5% of a person's body weight was considered a good result in the obesity research space
These simple adjustments often make a significant difference in your comfort level
As a younger therapeutic option, GLP-1 peptide Cagrilintide has higher production costs right now because it needs to be made using complicated peptide engineering and special purification methods
TB-500 research in the Journal of Peptide Science documented Thymosin Beta-4s role in cardiac repair following ischemic injury, with treated subjects demonstrating improved ejection fraction and reduced infarct size